EDIT Trademark

Trademark Overview


On Wednesday, October 19, 2022, a trademark application was filed for EDIT with the United States Patent and Trademark Office. The USPTO has given the EDIT trademark a serial number of 97638305. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 16, 2024. This trademark is owned by Saliogen Therapeutics, Inc.. The EDIT trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations for the treatment and prevention of genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias musculoskeletal, oncological disorders and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; reagents for medical and veterinary purposes being medical use; nucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acid vectors comprising nucleotides for medical and veterinary purposes, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes

Reagents for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; nucleic acids for laboratory use for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modifications for use in the fields of scientific research, clinical research, and scientific diagnostics research, namely, nucleic acids for laboratory use

General Information


Serial Number97638305
Word MarkEDIT
Filing DateWednesday, October 19, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias musculoskeletal, oncological disorders and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; reagents for medical and veterinary purposes being medical use; nucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acid vectors comprising nucleotides for medical and veterinary purposes, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes
Goods and ServicesReagents for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; nucleic acids for laboratory use for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modifications for use in the fields of scientific research, clinical research, and scientific diagnostics research, namely, nucleic acids for laboratory use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, November 3, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSaliogen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Party NameSaliogen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events


Event DateEvent Description
Friday, February 10, 2023NON-FINAL ACTION E-MAILED
Saturday, October 22, 2022NEW APPLICATION ENTERED
Thursday, November 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 31, 2023ASSIGNED TO EXAMINER
Friday, February 10, 2023NON-FINAL ACTION WRITTEN
Friday, February 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 15, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, April 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 15, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 11, 2023FINAL REFUSAL WRITTEN
Thursday, May 11, 2023FINAL REFUSAL E-MAILED
Thursday, May 11, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, August 10, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, August 11, 2023EXPARTE APPEAL RECEIVED AT TTAB
Friday, August 11, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, August 11, 2023EX PARTE APPEAL-INSTITUTED
Tuesday, August 15, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 15, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, August 15, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 15, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, August 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 30, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 19, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, October 26, 2023EXPARTE APPEAL DISMISSED AS MOOT
Thursday, October 26, 2023EXPARTE APPEAL TERMINATED
Tuesday, November 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 28, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 28, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 28, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 7, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 7, 2024SOU EXTENSION 1 FILED
Tuesday, May 7, 2024SOU EXTENSION 1 GRANTED
Wednesday, May 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED